List of contaminated cell lines

Last updated

Many cell lines that are widely used for biomedical research have been overgrown by other, more aggressive cells. For example, supposed thyroid lines were actually melanoma cells, supposed prostate tissue was actually bladder cancer, and supposed normal uterine cultures were actually breast cancer. [1] This is a list of cell lines that have been cross-contaminated and overgrown by other cells. Estimates based on screening of leukemia-lymphoma cell lines suggest that about 15% of these cell lines are not representative of what they are usually assumed to be. [2] A project is currently underway to enumerate and rename contaminated cell lines to avoid errors in research caused by misattribution. [3] [4] [lower-alpha 1]

Contents

Contaminated cell lines have been extensively used in research without knowledge of their true character. For example, most if not all research on the endothelium ECV-304 or the megakaryocyte DAMI cell lines has in reality been conducted on bladder carcinoma and erythroleukemia cells, respectively. Thus, all research on endothelium- or megakaryocyte-specific functions utilizing these cell lines has been misguided.

There are two principal ways in which a cell line can become contaminated: cell cultures are often exchanged between research groups; if, during handling, a sample is contaminated and then passed on, subsequent exchanges of cells will lead to the contaminating population being established, although parts of the supposed cell line are still genuine. More serious is contamination at the source: during establishment of the original cell line, some contaminating cells are accidentally introduced into the cultures, where they in time outgrow the desired cells. In this case, the initial testing still suggests that the cell line is genuine and novel, but in reality, it disappeared soon after being established, and all samples of such cell lines are actually the contaminating cells. Lengthy research is required to determine the precise points where cell lines became contaminated. A mix-up rated as contamination could in reality be a simple confusion of two cell lines, but usually contamination is assumed.[ citation needed ]

After a cell line has been discovered to be contaminated, it is usually never used again for research demanding the specific type of cell line they were assumed to be. Most contaminated cell lines are discarded; however, sometimes contaminant cells have acquired novel characteristics (e.g., by mutation or viral transfection, for example the HeLa derivate Det98) and thus constitute a truly novel lineage, so they are not thrown away. If a cell line is thought to be contaminated, it is usually tested for authenticity. [lower-alpha 2] The widespread contamination of HeLa cells was initially recognized by Walter Nelson-Rees using simple Giemsa stain karyotyping under a light microscope. This technique works well in recognizing HeLa because these cells have distinctive chromosome aberrations. Novel cell lines are proliferated and distributed and/or deposited at a safekeeping institution such as the ATCC as soon as possible after establishment to minimize the odds that the line becomes spoiled by contamination. It is considered good practice to periodically check cell lines maintained under laboratory conditions (i.e., not placed in long-term storage) for contamination with HeLa or other common contaminants to ensure that their quality and integrity are maintained.[ citation needed ]

Lists of contaminated cell lines

This list, containing 488 cell lines, was last updated on 1 December 2016. [lower-alpha 3]

Cellosaurus also is maintaining a list of "problematic" cell lines. [6] The list is dynamically generated from all cell lines in the database with a comment containing the dedicated words "Problematic cell line". As of 17 January 2017, the list contains 757 entries.

If no species is given in the individual entries of the following tables, the table's species applies to both the assumed and the actual cell types.

Cell lines marked Virtual in the table below are known instances of contamination at the source; these cell lines became extinct or never existed. Cases where non-contaminated lines are known or strongly suspected to exist are marked Existent.

Contaminated human cell lines

Supposed cell lineExistent?Supposed cell typeReal cell lineReal cell typeReference Cellosaurus
207Existent pre-B cell leukemia REH or CCRF-CEM pre-B cell or T cell leukemia [7] CVCL_K034
2474/90Virtual stomach carcinoma HT-29 colon carcinoma [7] CVCL_9556
2563, MAC-21 lung lymphoma HeLa cervical adenocarcinoma [8] CVCL_M629, CVCL_M627
2957/90Virtual stomach carcinoma HT-29 colon carcinoma [7] CVCL_9557
3051/80Virtual stomach carcinoma HT-29 colon carcinoma [7] CVCL_9558
ADLC-5M2Virtual lung carcinoma HeLa cervical adenocarcinoma [7] CVCL_8169
AG-FVirtual Hodgkin's disease CCRF-CEM variant T cell leukemia [9] CVCL_D101
AOVirtual amnion HeLa cervical adenocarcinoma [10] CVCL_D631
ARH-77Existent? plasma cell leukemia unknown Epstein-Barr virus-transfected B cell lymphoblastoid [9] CVCL_1072
AV3Virtual amnion HeLa cervical adenocarcinoma [10] CVCL_1904
BCC1/KMCVirtual basal cell carcinoma HeLa cervical adenocarcinoma [7] CVCL_A033
BE-13Virtual T cell leukemia PEER T cell leukemia Drexler et al. (2003) CVCL_1081
BJA-BExistent Burkitt's lymphoma REH pre-B cell leukemia Drexler et al. (2003) CVCL_5711
BLIN-1, -1E8Virtual pre-B cell leukemia NALM-6 pre-B cell leukemia Drexler et al. (2003) CVCL_8173
BM-1604Virtual prostate carcinoma DU-145 prostate carcinoma [7] CVCL_1968
BrCa 5Virtual breast carcinoma HeLa cervical adenocarcinoma [8] CVCL_D280
BT-20Existent breast carcinoma HeLa cervical adenocarcinoma [8] CVCL_0178
CaMa (cl 15)Virtual breast carcinoma unknown Laboratory mouse/Golden hamster cells [8] CVCL_1T14
CaOVVirtual ovarian carcinoma HeLa cervical adenocarcinoma [10] CVCL_M091
CaVeVirtual stomach carcinoma HeLa cervical adenocarcinoma [8] CVCL_8444
Chang liver liver HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_0238
CHBVirtual astrocytoma unknown Laboratory rat glial cells? [8] CVCL_1R45
CMP, CMPII C2Virtual intestinal adenocarcinoma HeLa cervical adenocarcinoma [10] CVCL_D297 CVCL_L115
CO (COLE)Virtual Hodgkin's disease CCRF-CEM T cell leukemia [9] CVCL_J653
COLO-818Virtual melanoma COLO-800 melanoma [7] CVCL_1998
D18TVirtual synovial cell HeLa cervical adenocarcinoma [10] CVCL_8669
DAMIVirtual megakaryocytic HEL erythroleukemia MacLeod et al. (1997a, b) CVCL_4360
DAPTVirtual pilocytic astrocytoma HeLa cervical adenocarcinoma [10] CVCL_D279
Detroit 6 (Det6)Virtual sternal marrow HeLa cervical adenocarcinoma [10] CVCL_2436
Detroit 30A (Det30A)Virtual carcinoma ascites HeLa cervical adenocarcinoma [10] CVCL_8674
Detroit 98 (Det98), Det98/AG,
Det98/AH-2, Det98/AHR
Virtual sternal marrow HeLa cervical adenocarcinoma [10] CVCL_8188
DDVirtual malignant histiocytosis K-562 terminal CML Drexler et al. (2003) CVCL_J651
EB33Virtual prostate HeLa cervical adenocarcinoma [10] CVCL_8344
ECV-304Virtualnormal endothelium T-24 bladder carcinoma Dirks et al. (1999); Lacroix (2008) CVCL_2029
EHVirtual hairy cell leukemia HK hairy cell leukemia Drexler et al. (2003) CVCL_L804
ElCoVirtual breast carcinoma HeLa cervical adenocarcinoma [10] CVCL_8686
EPLC-32M1Virtual lung carcinoma HeLa cervical adenocarcinoma [7] CVCL_8193
EPLC-65HVirtual lung carcinoma HeLa cervical adenocarcinoma [7] CVCL_8194
ESP1VirtualSporadic Burkitt's lymphoma HeLa cervical adenocarcinoma [10] CVCL_8351
EU-1Virtual pre-B cell leukemia REH pre-B cell leukemia Drexler et al. (2003) CVCL_8857
EU-7Virtual T cell leukemia CCRF-CEM T cell leukemia Drexler et al. (2003) CVCL_8865
EUEVirtual fetal subcutis HeLa cervical adenocarcinoma [8] CVCL_7262
EVLC2Virtualtransfected umbilical vein endothelium unknownnon-endothelial?Unger et al. (2002) CVCL_8687
F2-4E5Virtual thymus epithelium SK-HEP-1 liver carcinoma [7] CVCL_A040
F2-5B6Virtual thymus epithelium SK-HEP-1 liver carcinoma [7] CVCL_A041
F255A4Virtual HeLa cervical adenocarcinoma [8] CVCL_8688
FLVirtual amnion HeLa cervical adenocarcinoma [10] CVCL_1905
FQ, RB, RY, SpRVirtual Hodgkin's disease spleen OMK-210 Three-striped night monkey kidney [8] CVCL_L984, CVCL_L985,
CVCL_U964, CVCL_L986
G-11Virtual breast carcinoma HeLa cervical adenocarcinoma [8] CVCL_U962
GHEVirtual astrocytoma T-24bladder carcinoma [7] CVCL_8199
Girardi heart heart HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_2254
GM01312 myeloma unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_J111
GM01500 myeloma unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_D870
GREF-XVirtual liver myofibroblast unknown Laboratory rat cell line [7] CVCL_7667
HAEND liver angiosarcoma unknownnon-endothelial?Unger et al. (2002) CVCL_8690
hAGVirtual adenomatoid goitre T-24bladder carcinoma [7] CVCL_8223
HBCVirtual infiltrating ductal carcinoma unknown Rat cell line [8] CVCL_M630
HBT3, HBT-E, HBT-39bVirtual breast carcinoma HeLa cervical adenocarcinoma [10] CVCL_D281, CVCL_M746,
CVCL_J652
HCEVirtual cervical carcinoma HeLa cervical adenocarcinoma [10] CVCL_M619
HEKVirtual embryonic kidney HeLa cervical adenocarcinoma [10] CVCL_M624
HEK/HRVtransfected embryonic kidney HeLa cervical adenocarcinoma [10] CVCL_M625
HEL-R66Virtual embryonic lung unknown Grivet cell line [8] CVCL_1R39
HEp-2Virtual larynx epidermoid carcinoma HeLa cervical adenocarcinoma Chen (1988); Lacroix (2008) CVCL_1906
HIMeg-1Existent? CML HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_8439
HKB-1Virtual Hodgkin's disease unknownunknownDrexler et al. (2003) CVCL_5290
HMV-1Virtual melanoma HeLa cervical adenocarcinoma [7] CVCL_8233
HPB-ALLExistent T cell leukemia Jurkat T cell leukemia Drexler et al. (2003) CVCL_1820
HPB-MLTVirtual T cell leukemia HPB-ALL T cell leukemia Drexler et al. (2003) CVCL_7959
hPTCVirtual papillary thyroid carcinoma unknown Domestic pig cell line [7] CVCL_8224
HS-445 Hodgkin's disease unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_0761
HS-SultanVirtual multiple myeloma plasmacytoma JijoyeEndemic Burkitt's lymphoma Drexler et al. (2001) CVCL_2516
HuK°39Virtual kidney HeLa cervical adenocarcinoma [8] CVCL_8283
HuTVirtual fibrosarcoma-derived cell line 8387 HeLa cervical adenocarcinoma [8] CVCL_M861
IM-9 multiple myeloma unknown Epstein-Barr virus-transfected B cell lymphoblastoid ; [9] Lacroix (2008) CVCL_1305
IMC-2Virtual maxillary carcinoma HeLa cervical adenocarcinoma [7] CVCL_8245
Intestine 407 (INT 407)Virtual intestinal epithelium HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_1907
J96Virtual leukemic blood HeLa cervical adenocarcinoma [10] CVCL_3990
J111Virtual monocytic leukemia HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_2965
JHCVirtual placenta HeLa cervical adenocarcinoma [10] CVCL_M093
JHTVirtualtransfected placenta HeLa cervical adenocarcinoma [8] CVCL_M620
JOSK-I, -K, -M, -SVirtual monocytic leukemia U-937 histiocytic lymphoma [7] CVCL_2082, CVCL_81411,
CVCL_2083, CVCL_8142
K051Existent? myeloblastic leukemia K-562 terminal CML Drexler et al. (2003) CVCL_3000
Karpas 45Existent T cell leukemia unknownunknown [9] CVCL_1326
KBVirtualoral carcinoma HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_0372
KBM-3Existent monocytic leukemia HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_A425
KE-37Existent T cell leukemia CCRF-CEM T cell leukemia [9] CVCL_1327
KM-3Existent? pre-B cell leukemia REH pre-B cell leukemia [9] CVCL_0011
KMS-21-BMExistent? myeloma unknownunknownDrexler et al. (2003) CVCL_2991
KPB-M15Virtualterminal CML KYO-1terminal CML Drexler et al. (2003) CVCL_5308
KP-P1Virtual prostate carcinoma HeLa cervical adenocarcinoma [10] CVCL_D283
L132Virtual embryonic lung epithelium HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_1908
L-540Existent Hodgkin's disease CCRF-CEM T cell leukemia Drexler et al. (2003) CVCL_1362
L-591Existent? Hodgkin's disease unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_1867
LED-Ti cervical carcinoma HeLa cervical adenocarcinoma [8] CVCL_8438
LR10.6Virtual pre-B cell leukemia NALM-6 pre-B cell leukemia [7] CVCL_8260
LUVirtual fetal lung HeLa cervical adenocarcinoma [8] CVCL_M631
LU 106Virtual embryonic lung HeLa cervical adenocarcinoma [8] CVCL_8892
M10TVirtual synovial cell HeLa cervical adenocarcinoma [10] CVCL_M094
MA160Virtual prostate HeLa cervical adenocarcinoma [10] CVCL_8261
MaTuVirtual breast carcinoma HeLa cervical adenocarcinoma [7] CVCL_5328
MB-02Existent megakaryoblastic leukemia HU-3 megakaryoblastic leukemia [9] CVCL_7075
MC-4000Virtual breast carcinoma HeLa cervical adenocarcinoma [7] CVCL_5331
MC/CAR plasma cell leukemia unknown Epstein-Barr virus-transfected B cell lymphoblastoid [9] CVCL_1397
McCoyVirtual synovial cellStrain L Laboratory mouse connective tissue [10] CVCL_3742
MDA-MB-435Virtual breast carcinoma M14 melanoma Ellison et al. J Clin Pathol Mol Pathol 55, 294-9; Lacroix (2008) CVCL_0417
MDSVirtual monocytic leukemia Jurkat T cell leukemia Drexler et al. (2003) CVCL_L807
MHH-225Existent? megakaryoblastic leukemia Jurkat T cell leukemia Drexler et al. (2003) CVCL_8894
Minnesota EEVirtual esophageal epithelium HeLa cervical adenocarcinoma [10] CVCL_8264
MKB-1Virtual T cell leukemia CCRF-CEM T cell leukemia [7] CVCL_8265
MOBS-1Virtual monocytic leukemia U-937 histiocytic lymphoma [9] CVCL_8442
MOLT-15Virtual T cell leukemia CTV-1 monocytic leukemia [7] CVCL_8150
MT-1Virtual breast carcinoma HeLa cervical adenocarcinoma ; [7] Lacroix (2008) CVCL_0441
MUTZ-1Virtual T cell leukemia Namalwa Burkitt's lymphoma [9] CVCL_1431
NCTC2544, NCTC3075Virtual skin epithelium HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_0461, CVCL_8156
NCI-ADR-RES Virtual breast cancer OVCAR-8 high grade serous ovarian cancer Liscovitch & Ravid (2007) CVCL_1452
NOI-90Virtual natural killer cell lymphoma REH pre-B cell leukemia Drexler et al. (2003) CVCL_8462
OEVirtual endometrium HeLa cervical adenocarcinoma [10] CVCL_J350
OU-AML-1, -2. -3, -4,
-5, -6, -7, -8
Virtual acute myeloid leukemia OCI/AML2 monocytic leukemia Drexler et al. (2003) CVCL_8391, CVCL_8392,
CVCL_8393, CVCL_8394,
CVCL_8395, CVCL_8396,
CVCL_8397, CVCL_8398
P1-1A3Virtual thymus epithelium SK-HEP-1 liver carcinoma [7] CVCL_A042
P1-4D6Virtual thymus epithelium SK-HEP-1 liver carcinoma [7] CVCL_A046
P39/TsuganeExistent myeloblastic leukemia HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_0478
PBEIVirtual pre-B cell leukemia NALM-6 pre-B cell leukemia [7] CVCL_8270
PLB-985Virtual monocytic leukemia HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_2162
RAMAK-1Virtual muscle synovium T-24bladder carcinoma [7] CVCL_8271
RBHF-1Virtual hepatoma unknownnon-human mammal cell line [7] CVCL_Y465
RC-2AExistent? monocytic leukemia CCRF-CEM T cell leukemia [9] CVCL_L808
RED-3Virtual acute myeloid leukemia HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_8907
REH-6Virtual pre-B cell leukemia unknown Laboratory mouse cell line [9] CVCL_L803
RM-10Virtualterminal CML K-562 terminal CML [9] CVCL_8463
RPMI-6666 Hodgkin's disease unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_1665
RPMI-8402Existent T cell leukemia unknownunknown; [9] Lacroix (2008) CVCL_1667
RS-1Existent? megakaryoblastic leukemia K-562 terminal CML Drexler et al. (2003) CVCL_8423
Rsp Hodgkin's disease unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_M628
RT4Existentbladder carcinoma HeLa cervical adenocarcinoma [10] CVCL_0036
SA4Virtual liposarcoma HeLa cervical adenocarcinoma [10] CVCL_8910
SAM-1Virtualterminal CML K-562 terminal CML Drexler et al. (2003) CVCL_8440
SBC-2Virtualbladder carcinoma HeLa cervical adenocarcinoma [7] CVCL_1677
SBC-7Virtualbladder carcinoma HeLa cervical adenocarcinoma [7] CVCL_1680
SCLC-16H, -24HVirtual small cell lung carcinoma SCLC-21/22H small cell lung carcinoma [7] CVCL_X025, CVCL_8262
SH-2Virtual breast carcinoma HeLa cervical adenocarcinoma [10] CVCL_M622
SH-3Virtual breast carcinoma HeLa cervical adenocarcinoma [10] CVCL_M383
SPI-801, -802Virtual T cell leukemia K-562 terminal CML [7] CVCL_2200, CVCL_2201
SR-91Virtual T cell leukemia AML-193 monocytic leukemia Drexler et al. (2003) CVCL_8441
SW-527Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_3799
SW-598Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_F649
SW-608Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_F653
SW-613Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_F650
SW-732Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_F651
SW-733Virtual tumor SW-480/SW-620 colon adenocarcinoma [8] CVCL_F652
T-1Virtual kidney HeLa cervical adenocarcinoma [8] CVCL_M858
T-9Virtualtransfected somatic HeLa cervical adenocarcinoma [10] CVCL_M092
T-33Existent?terminal CML K-562 terminal CML Drexler et al. (2003) CVCL_8427
TDL-1, TDL-2Virtual tonsil lymphoidP3JHR-1 Burkitt's lymphoma [8] CVCL_8428, CVCL_8429
TDL-3Virtual tonsil lymphoidRPMI-1788 lymphoblastoid [8] CVCL_8430
TDL-4Virtual tonsil lymphoid Raji Burkitt's lymphoma [8] CVCL_8431
TI-1Virtual myeloblastic leukemia K-562 terminal CML Drexler et al. (2003) CVCL_L806
TMMterminal CML unknown Epstein-Barr virus-transfected B cell lymphoblastoid [9] CVCL_1894
TuWiVirtual Wilms' Tumor HeLa cervical adenocarcinoma [10] CVCL_8275
U-937 Existent histiocytic lymphoma unknownunknown [9] CVCL_0007
UMJF-2 myeloma unknown Epstein-Barr virus-transfected B cell lymphoblastoid Drexler et al. (2003) CVCL_M548
UT-7Existent histiocytic lymphoma unknownunknown [9] CVCL_2233
UTMB-460Virtual B cell CCRF-CEM T cell leukemia Drexler et al. (2003) CVCL_8276
WISHVirtual amnion HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_1909
Wong-KilbourneVirtual conjunctiva HeLa cervical adenocarcinoma ; [10] Lacroix (2008) CVCL_2764
WSU-ALCLVirtual Anaplastic large cell lymphoma CCRF-CEM T cell leukemia Drexler et al. (2003) CVCL_A036
WSU-CLLVirtual B cell leukemia REH pre-B cell leukemia Drexler et al. (2002a) CVCL_A049
YAAVirtual monocyte U-937 histiocytic lymphoma Drexler et al. (2003) CVCL_8466
YAPVirtual monocyte U-937 histiocytic lymphoma Drexler et al. (2003) CVCL_8467
YJVirtual monocytic leukemia HL-60 myeloblastic leukemia Drexler et al. (2003) CVCL_8931

Contaminated non-human cell lines

Supposed cell lineExistent?Supposed cell typeReal cell lineReal cell typeReference Cellosaurus
GPS-M, GPS-PD Guinea pig spleen Strain L-M Laboratory mouse connective tissue [8] CVCL_1R31, CVCL_1R32
LT-1 Leopard frog renal adenocarcinoma TH-1/FHM Eastern box turtle heart / Fathead minnow epithelium [8] CVCL_1R49

Notes

  1. The original citation was ambiguous on which of these citations was being referenced, so both have been added here.
  2. The citations of this article contain some papers on how common contaminates can be recognized.
  3. An updated list can be obtained from International Cell Line Authentication Committee website. [5]

Related Research Articles

<span class="mw-page-title-main">HeLa</span> Oldest cultured human cell line (1951)

HeLa is an immortalized cell line used in scientific research. It is the oldest human cell line and one of the most commonly used. HeLa cells are durable and prolific, allowing for extensive applications in scientific study. The line is derived from cervical cancer cells taken on 8 February 1951, from Henrietta Lacks, a 31-year-old African American mother of five, after whom the line is named. Lacks died of cancer on 4 October 1951.

<span class="mw-page-title-main">Cell culture</span> Process by which cells are grown under controlled conditions

Cell culture or tissue culture is the process by which cells are grown under controlled conditions, generally outside of their natural environment. After cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. They need to be kept at body temperature (37 °C) in an incubator. These conditions vary for each cell type, but generally consist of a suitable vessel with a substrate or rich medium that supplies the essential nutrients (amino acids, carbohydrates, vitamins, minerals), growth factors, hormones, and gases (CO2, O2), and regulates the physio-chemical environment (pH buffer, osmotic pressure, temperature). Most cells require a surface or an artificial substrate to form an adherent culture as a monolayer (one single-cell thick), whereas others can be grown free floating in a medium as a suspension culture. This is typically facilitated via use of a liquid, semi-solid, or solid growth medium, such as broth or agar. Tissue culture commonly refers to the culture of animal cells and tissues, with the more specific term plant tissue culture being used for plants. The lifespan of most cells is genetically determined, but some cell-culturing cells have been 'transformed' into immortal cells which will reproduce indefinitely if the optimal conditions are provided.

<span class="mw-page-title-main">Adult T-cell leukemia/lymphoma</span> Human disease

Adult T-cell leukemia/lymphoma is a rare cancer of the immune system's T-cells caused by human T cell leukemia/lymphotropic virus type 1 (HTLV-1). All ATL cells contain integrated HTLV-1 provirus further supporting that causal role of the virus in the cause of the neoplasm. A small amount of HTLV-1 individuals progress to develop ATL with a long latency period between infection and ATL development. ATL is categorized into 4 subtypes: acute, smoldering, lymphoma-type, chronic. Acute and Lymphoma-type are known to particularity be aggressive with poorer prognosis.

K562 cells were the first human immortalised myelogenous leukemia cell line to be established. K562 cells are of the erythroleukemia type, and the cell line is derived from a 53-year-old female chronic myelogenous leukemia patient in blast crisis. The cells are non-adherent and rounded, are positive for the bcr:abl fusion gene, and bear some proteomic resemblance to both undifferentiated granulocytes and erythrocytes.

Jurkat cells are an immortalized line of human T lymphocyte cells that are used to study acute T cell leukemia, T cell signaling, and the expression of various chemokine receptors susceptible to viral entry, particularly HIV. Jurkat cells can produce interleukin 2, and are used in research involving the susceptibility of cancers to drugs and radiation.

THP-1 is a human monocytic cell line derived from an acute monocytic leukemia patient. It is used to test leukemia cell lines in immunocytochemical analysis of protein-protein interactions, and immunohistochemistry.

<span class="mw-page-title-main">CEBPA</span> Protein-coding gene in the species Homo sapiens

CCAAT/enhancer-binding protein alpha is a protein encoded by the CEBPA gene in humans. CCAAT/enhancer-binding protein alpha is a transcription factor involved in the differentiation of certain blood cells. For details on the CCAAT structural motif in gene enhancers and on CCAAT/Enhancer Binding Proteins see the specific page.

<span class="mw-page-title-main">TLX3</span> Protein-coding gene in the species Homo sapiens

T-cell leukemia homeobox protein 3 is a protein that in humans is encoded by the TLX3 gene.

<span class="mw-page-title-main">MNX1</span> Protein-coding gene in the species Homo sapiens

Motor neuron and pancreas homeobox 1 (MNX1), also known as Homeobox HB9 (HLXB9), is a human protein encoded by the MNX1 gene.

<span class="mw-page-title-main">BCL11B</span> Protein-coding gene in the species Homo sapiens

B-cell lymphoma/leukemia 11B is a protein that in humans is encoded by the BCL11B gene.

<span class="mw-page-title-main">BLZF1</span> Protein-coding gene in the species Homo sapiens

Golgin-45 is a protein that in humans is encoded by the BLZF1 gene.

<span class="mw-page-title-main">Protein BEX2</span> Protein-coding gene in the species Homo sapiens

Protein BEX2 also known as brain-expressed X-linked protein 2 is a protein that in humans is encoded by the BEX2 gene.

A hypomethylating agent is a drug that inhibits DNA methylation: the modification of DNA nucleotides by addition of a methyl group. Because DNA methylation affects cellular function through successive generations of cells without changing the underlying DNA sequence, treatment with a hypomethylating agent is considered a type of epigenetic therapy.

<span class="mw-page-title-main">Immortalised cell line</span> Lineage of cells that evades senescence and continues dividing

An immortalised cell line is a population of cells from a multicellular organism which would normally not proliferate indefinitely but, due to mutation, have evaded normal cellular senescence and instead can keep undergoing division. The cells can therefore be grown for prolonged periods in vitro. The mutations required for immortality can occur naturally or be intentionally induced for experimental purposes. Immortal cell lines are a very important tool for research into the biochemistry and cell biology of multicellular organisms. Immortalised cell lines have also found uses in biotechnology.

<span class="mw-page-title-main">Raji cell</span> Human cell line

Raji is the first continuous human cell line of hematopoietic origin. The Raji cell line is widely used as a transfection host.

Cellosaurus is an online knowledge base on cell lines, which attempts to document all cell lines used in biomedical research. It is provided by the Swiss Institute of Bioinformatics (SIB). It is an ELIXIR Core Data Resource as well as an IRDiRC's Recognized Resource. It is the contributing resource for cell lines on the Resource Identification Portal. As of December 2022, it contains information for more than 144,000 cell lines.

The NCI-60 cancer cell line panel is a group of 60 human cancer cell lines used by the National Cancer Institute (NCI) for the screening of compounds to detect potential anticancer activity.

TF-1 cells are immortal cell line derived from the human Erythroleukemia used in biomedical research. This cells are proliferatively responsive to interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). TF-1 cells have gene fusion of CBFA2T3-ABHD12.

The LL-100 panel is a group of 100 human leukemia and lymphoma cell line, can be used in model of biomedical research.

The HEL cell line is an immortalised cell line from a 30-year old male Acute erythroid leukemia patient, used in biomedical research.

References

  1. Jill Neimark (27 February 2015). "Line of attack". Science. 347 (6225): 938–940. Bibcode:2015Sci...347..938N. doi: 10.1126/science.347.6225.938 . PMID   25722392.
  2. Masters, John R. (April 2002). "HeLa cells 50 years on: the good, the bad and the ugly". Nature Reviews Cancer. 2 (4): 315–319. doi:10.1038/nrc775. ISSN   1474-175X. PMID   12001993. S2CID   991019.
  3. Drexler, H. G.; Quentmeier, H.; Dirks, W. G.; Uphoff, C. C.; MacLeod, R. a. F. (September 2002). "DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL)". Leukemia. 16 (9): 1868–1870. doi: 10.1038/sj.leu.2402610 . ISSN   1476-5551. PMID   12200708.
  4. Drexler, Hans G.; Uphoff, Cord C.; Dirks, Willy G.; MacLeod, Roderick A. F. (2002-04-01). "Mix-ups and mycoplasma: the enemies within". Leukemia Research. 26 (4): 329–333. doi:10.1016/S0145-2126(01)00136-9. ISSN   0145-2126. PMID   11839374.
  5. "Database of Cross-Contaminated or Misidentified Cell Lines" (PDF). iclac.org. January 12, 2016. Retrieved 2019-05-10.
  6. "Cellosaurus search result: 757 hits for 'problematic cell line'". Cellosaurus . Swiss Institute of Bioinformatics . Retrieved 17 January 2018. The reference includes the list of linked pages in the search result.
  7. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 Dirks, Wilhelm G.; MacLeod, Roderick A. F.; Drexler, Hans G. (November 1999). "ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source". In Vitro Cellular & Developmental Biology - Animal. 35 (10): 558–559. doi:10.1007/s11626-999-0091-8. ISSN   1071-2690. PMID   10614862. S2CID   31347874.
  8. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Nelson-Rees, W.; Daniels, D.; Flandermeyer, R. (1981-04-24). "Cross-contamination of cells in culture". Science. 212 (4493): 446–452. Bibcode:1981Sci...212..446N. doi:10.1126/science.6451928. ISSN   0036-8075. PMID   6451928.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Drexler, Hg; Dirks, Wg; MacLeod, Raf (October 1999). "False human hematopoietic cell lines: cross-contaminations and misinterpretations". Leukemia. 13 (10): 1601–1607. doi: 10.1038/sj.leu.2401510 . ISSN   0887-6924. PMID   10516762.
  10. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Nelson-Rees, W. A.; Flandermeyer, R. R. (1976). "HeLa cultures defined". Science . 191 (4222): 96–98. Bibcode:1976Sci...191...96N. doi:10.1126/science.1246601. PMID   1246601.

Bibliography